tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Diagnostic Advances and Strategic Collaborations Justify Buy Rating for Mainz Biomed
PremiumRatingsPromising Diagnostic Advances and Strategic Collaborations Justify Buy Rating for Mainz Biomed
2M ago
Mainz Biomed reports results from feasibility study of biomarker panel
Premium
The Fly
Mainz Biomed reports results from feasibility study of biomarker panel
2M ago
Mainz Biomed Enters $10 Million Equity Distribution Agreement with Maxim Group
Premium
Company Announcements
Mainz Biomed Enters $10 Million Equity Distribution Agreement with Maxim Group
2M ago
Mainz Biomed receives Swiss regulatory approval to market ColoAlert
PremiumThe FlyMainz Biomed receives Swiss regulatory approval to market ColoAlert
4M ago
Mainz Biomed Secures $3 Million Through Securities Purchase Agreement
Premium
Company Announcements
Mainz Biomed Secures $3 Million Through Securities Purchase Agreement
4M ago
Mainz Biomed files to sell 1.47M ordinary units
Premium
The Fly
Mainz Biomed files to sell 1.47M ordinary units
4M ago
Mainz initiates feasibility study of biomarker panel in PancAlert project
PremiumThe FlyMainz initiates feasibility study of biomarker panel in PancAlert project
6M ago
Mainz Biomed N.V. Shareholders Approve Key Proposals at Annual Meeting
Premium
Company Announcements
Mainz Biomed N.V. Shareholders Approve Key Proposals at Annual Meeting
6M ago
Mainz Biomed N.V. Secures $4 Million Through Securities Offering
Premium
Company Announcements
Mainz Biomed N.V. Secures $4 Million Through Securities Offering
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100